Research Archive — Page 110 of 137
-
January 17, 2019
Signals from the “conveyor belt”
Vanderbilt researchers propose that cellular signaling pathways are amplified by a “conveyor belt” mechanism that exchanges active and inactive enzymes. -
January 17, 2019
Pain relievers a risk for C. diff?
A link between anti-inflammatory drugs such as ibuprofen and C. diff infection suggests caution against overusing such drugs in patients at high risk for infection. -
January 17, 2019
DNA’s on/off switch
DNA-binding “switches” represent a fundamentally new method of communication between DNA-processing enzymes, Vanderbilt researchers propose. -
January 17, 2019
Building a pancreas
Vanderbilt investigators are defining the genetic programs that control the development of pancreatic beta cells — studies that could inform new cellular or regenerative therapies for diabetes. -
January 10, 2019
Study identifies novel genetic factors for colorectal cancer risk
A large-scale study conducted among East Asians and led by Vanderbilt researchers has identified multiple, previously unknown genetic risk factors for colorectal cancer. -
January 10, 2019
Bile acids mediate metabolic benefits of weight-loss surgery
A team of Vanderbilt investigators has pinpointed the role of bile acids and a specific signaling pathway in the positive metabolic effects of weight-loss surgery. -
December 31, 2018
Hundreds of new blood pressure gene variations discovered